康拓医疗8月26日获融资买入1649.82万元，融资余额1.33亿元

Group 1 - The core viewpoint of the news is that Kangtuo Medical has shown stable trading activity with a slight increase in financing and a notable balance in margin trading as of August 26 [1] - On August 26, Kangtuo Medical's stock price remained unchanged at 0.00%, with a trading volume of 105 million yuan and a financing buy-in amount of 16.49 million yuan, while the financing repayment was 20.12 million yuan, resulting in a net financing outflow of 3.62 million yuan [1] - As of August 26, the total margin trading balance for Kangtuo Medical was 133 million yuan, which accounts for 4.10% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of March 31, the number of shareholders for Kangtuo Medical increased by 10.54% to 4,435, while the average circulating shares per person decreased by 9.54% to 18,317 shares [2] - For the first quarter of 2025, Kangtuo Medical reported a revenue of 82.49 million yuan, representing a year-on-year growth of 17.98%, and a net profit attributable to shareholders of 24.05 million yuan, which is a 20.63% increase year-on-year [2] - Since its A-share listing, Kangtuo Medical has distributed a total of 152 million yuan in dividends, with 85.42 million yuan distributed over the past three years [3]